- News en
New collaboration with Breathlabs to further develop the analysis of biomarkers from exhaled air
Breath analysis is an innovative method that examines chemical substances in exhaled air. As breath contains over 1,000 different compounds, it offers a unique insight into the state of health of the body. In medical diagnostics, biomarkers are used to detect respiratory diseases, metabolic disorders and cancer. Thanks to its non-invasive, quick and painless application, breath gas analysis has an enormous potential to sustainably improve health monitoring.
In a strategic partnership with the US company Breathlabs, Hahn-Schickard aims to enrich respiratory gas health monitoring with technologies such as AI, machine learning and multi-modal sensor technology. Breathlabs will be integrated as a partner in the Hahn-Schickard Application Hub in Ulm to promote the development of innovative solutions in the field of personalized medicine and diagnostics. In the Application Hub at Hahn-Schickard's Ulm site, analytical measurement and sensor technologies are demonstrated to industry, cooperation partners and specialist users using real, experimental examples and scenarios in order to initiate targeted device development and application-oriented projects.
Hahn-Schickard Institute Director Professor Boris Mizaikoff hopes that “the cooperation with Breathlabs represents a further important step towards improved disease screening in order to break new ground, especially in the early detection of diseases, but also in therapy support”.
Contact
Competences
- Analytical and bioanalytical chemistry
- Infrared spectroscopy and sensing
- Biomimetic molecular recognition architectures
- Integrated photonic systems